Orexo's share is listed on NasdaqOMX Stockholm, Sweden (ORX), and is available as American Depository Receipts on OTCQX market in the US (OXROY).
Share price
Name
0.00
0 SEK (0%)
HH:MM CET • 20YY-MM-DD
Latest financial report
Interim Report Q4 2020, incl. Full Year Report, Jan. 28
PDF | AudioCast | Presentation
APRIL 13, 2021
Report from the Annual General Meeting
Latest presentations
Find your topic of interest
Analyst reports
Investment thesis
Latest CEO Comments
JANUARY 28, 2021
"Progress while adjusting to new market dynamics"
Read the latest CEO comments from Nikolaj Sørensen
News flow
Key financial figures
Group net revenue
663.6 MSEK
Last Twelve Months, Q120-Q420
Group EBITDA
19.0 MSEK
Last Twelve Months, Q120-Q420
US Pharma segment EBIT
331.2 MSEK
Last Twelve Months, Q120-Q420
Cash position
505.3 MSEK
Q420
